FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13177411000001101: Megace 160mg tablets (Dowelhurst Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
46446701000001117 Megace 160mg tablets (Dowelhurst Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
46446801000001114 Megace 160mg tablets (Dowelhurst Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Megace 160mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Is a Product containing precisely megestrol acetate 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has active ingredient Megestrol acetate false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Is a Megace true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has specific active ingredient Megestrol acetate true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Megace 160mg tablets (Dowelhurst Ltd) 30 tablet Is pack of False Megace 160mg tablets (Dowelhurst Ltd) Inferred relationship Existential restriction modifier
Megace 160mg tablets (Dowelhurst Ltd) 30 tablet Has AMP True Megace 160mg tablets (Dowelhurst Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start